Usefulness of contrast enhanced three-dimensional ultrasonography in assessing treatment effects.

Usefulness of contrast enhanced three-dimensional ultrasonography in assessing treatment effects. - Treatment effects assessed by contrast enhanced 3D ultrasonography.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003292

Enrollment

300

Registered

2010-03-05

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver neoplasm

Interventions

Contrast enhanced three-dimensional ultrasonography using sonazoid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with liver neoplasm 2. Written informed consent

Exclusion criteria

Exclusion criteria: Allergy for egg

Design outcomes

Primary

Measure	Time frame
The ability of assessing treatment effects.	—

Countries

Japan

Contacts

Public ContactJun Imamura

Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Division of Hepatology, Department of Internal Medicine

jun.imamu@gmail.com03-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026